CVS HEALTH (CVS) DIvidends Date & History

Key Takeaways

• CVS Health pays a quarterly dividend of $0.665 per share, totaling $2.66 annually.
• The current dividend yield stands at approximately 2.55%.
• The trailing payout ratio exceeds 100% of earnings but remains covered by free cash flow.
• The company has maintained consistent quarterly payments with a history of gradual increases.
• Dividend growth averaged about 5.9% annually over the past five years.
• The stock suits income-focused investors seeking stability in the healthcare sector.

Dividend Overview

CVS Health Corporation distributes dividends on a quarterly schedule. The most recent payment of $0.665 per share was declared in March 2026, with an ex-dividend date of April 23, 2026, and payment on May 4, 2026. Annualized, the dividend totals $2.66 per share. This produces a yield near 2.55% based on recent share prices. The company follows a policy of regular quarterly distributions, positioning it as a modest-yield dividend payer rather than a high-yield income vehicle. Investors view CVS as a steady dividend stock within the healthcare industry.

Dividend History and Growth

CVS Health has paid quarterly dividends consistently for many years. The current $0.665 quarterly rate has held steady in recent declarations. Over the past five years, the dividend has grown at an average annual rate of approximately 5.9%. The company has increased its dividend for four consecutive years. No recent cuts appear in the record, reflecting a commitment to gradual growth aligned with earnings and cash generation. This track record supports classification as a dividend growth stock with a focus on long-term consistency.

Dividend Sustainability and Payout Ratio

The trailing twelve-month payout ratio stands above 100% of reported earnings, indicating dividends exceed current net income on a reported basis. However, coverage improves significantly when measured against free cash flow, with ratios typically in the 17% to 43% range. This cash flow support, combined with the company’s strong balance sheet and diversified operations in pharmacy and health services, suggests the dividend remains sustainable. Management has prioritized maintaining payments while managing debt levels effectively. Future sustainability will depend on earnings recovery and continued cash generation.

Dividend Compared to Industry Peers

Within the healthcare and pharmacy retail sector, CVS Health’s yield of about 2.55% compares favorably to many peers. Similar companies often offer yields between 1.5% and 3.0%, depending on their business mix and payout policies. CVS provides a balanced profile with quarterly payments and a modest growth history, distinguishing it from higher-yielding but potentially less stable names or lower-yielding growth-oriented healthcare firms. Relative to broad market averages, the yield appears competitive for a large-cap healthcare dividend stock.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.

Is This Stock Attractive for Dividend Investors?

CVS Health may appeal to income-oriented investors seeking regular quarterly distributions and a history of gradual dividend growth. Its yield and payment consistency could suit conservative portfolios focused on healthcare exposure. Dividend growth investors might appreciate the multi-year increase track record, though the current payout ratio on earnings warrants monitoring. Long-term holders could value the company’s scale and cash flow generation as supports for ongoing distributions. The stock does not target high-yield seekers but offers a measured profile for those prioritizing reliability over aggressive income. Investors should evaluate personal objectives and market conditions before considering any position.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations